SCHEMBL29436214

SCHEMBL29436214

O=C(Cn1nc(-c2ccccc2)ccc1=O)Nc1ccc2[nH]ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ PKM P14618 2/20 0.58
▸ ADRB2 P07550 1/20 0.58
▸ LMNA P02545 4/20 0.58
▸ USP2 O75604 2/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ TSHR P16473 2/20 0.52
▸ HTT P42858 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ MAPT P10636 6/20 0.51
▸ POLB P06746 1/20 0.50
▸ ALOX15 P16050 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23495306 1.00 KDM4E (0.58) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL23495217 0.90 ALDH1A1 (0.62) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL29436171 0.82 ALDH1A1 (0.62) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL23495394 0.82 ALDH1A1 (0.62) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL31703309 0.81 ALDH1A1 (0.74) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL31703255 0.79 KDM4E (0.72) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL23495383 0.78 KDM4E (0.57) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL29436223 0.78 KDM4E (0.57) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL31703317 0.77 KDM4E (0.57) KDM4EALDH1A1MEN1KMT2APKM
SCHEMBL24038931 0.77 KMT2A (0.66) ALDH1A1MEN1KMT2APKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340526-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS INC (US) 2025-11-06 — — US disclosed
US-12415794-B2 Pyridazinone compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2025-09-16 — — US disclosed
US-20230293518-A1 SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES EDGEWISE THERAPEUTICS, INC. 2023-09-21 — — US disclosed
US-20220081410-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) 2022-03-17 — — US disclosed
US-11236065-B2 Pyridazinone compounds and uses thereof EDGEWISE THERAPECUTICS, INC. (US) 2022-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293518-A1 SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES IL6, MUSK, SMN1; SMN2 KDM4E 3081/4885ALDH1A1 308/4885MEN1 4467/4885
US-20220081410-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF IL6, IL1B, IL1A KDM4E 3514/4885ALDH1A1 270/4885MEN1 4368/4885
US-12415794-B2 Pyridazinone compounds and uses thereof IL6, IL1B, IL1A KDM4E 3514/4885ALDH1A1 270/4885MEN1 4368/4885
US-11236065-B2 Pyridazinone compounds and uses thereof IL6, IL1B, IL1A KDM4E 3514/4885ALDH1A1 270/4885MEN1 4368/4885
US-20250340526-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF IL6, IL1B, IL1A KDM4E 3514/4885ALDH1A1 270/4885MEN1 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback